nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—ALB—chronic obstructive pulmonary disease	0.314	1	CbGaD
Levothyroxine—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.0757	0.187	CbGbCtD
Levothyroxine—SLCO1A2—Prednisone—chronic obstructive pulmonary disease	0.0715	0.177	CbGbCtD
Levothyroxine—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0515	0.127	CbGbCtD
Levothyroxine—ALB—Prednisone—chronic obstructive pulmonary disease	0.0369	0.0913	CbGbCtD
Levothyroxine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0364	0.0899	CbGbCtD
Levothyroxine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0246	0.0607	CbGbCtD
Levothyroxine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0234	0.0579	CbGbCtD
Levothyroxine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0209	0.0516	CbGbCtD
Levothyroxine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0205	0.0506	CbGbCtD
Levothyroxine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0193	0.0478	CbGbCtD
Levothyroxine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0123	0.0303	CbGbCtD
Levothyroxine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0116	0.0286	CbGbCtD
Levothyroxine—THRA—connective tissue—chronic obstructive pulmonary disease	0.0023	0.071	CbGeAlD
Levothyroxine—SLCO4C1—trachea—chronic obstructive pulmonary disease	0.00201	0.0621	CbGeAlD
Levothyroxine—SLC7A5—respiratory system—chronic obstructive pulmonary disease	0.00199	0.0615	CbGeAlD
Levothyroxine—TTR—respiratory system—chronic obstructive pulmonary disease	0.00194	0.0599	CbGeAlD
Levothyroxine—SLC7A5—connective tissue—chronic obstructive pulmonary disease	0.00175	0.0541	CbGeAlD
Levothyroxine—SLC16A2—trachea—chronic obstructive pulmonary disease	0.00175	0.054	CbGeAlD
Levothyroxine—TTR—connective tissue—chronic obstructive pulmonary disease	0.00171	0.0527	CbGeAlD
Levothyroxine—SLC7A5—bronchus—chronic obstructive pulmonary disease	0.00164	0.0506	CbGeAlD
Levothyroxine—SLC7A5—smooth muscle tissue—chronic obstructive pulmonary disease	0.0016	0.0495	CbGeAlD
Levothyroxine—SLC7A5—trachea—chronic obstructive pulmonary disease	0.00147	0.0455	CbGeAlD
Levothyroxine—SLCO4C1—lung—chronic obstructive pulmonary disease	0.00144	0.0447	CbGeAlD
Levothyroxine—SLCO4A1—bronchus—chronic obstructive pulmonary disease	0.00143	0.0442	CbGeAlD
Levothyroxine—SLCO1B3—lung—chronic obstructive pulmonary disease	0.0014	0.0434	CbGeAlD
Levothyroxine—THRA—lung—chronic obstructive pulmonary disease	0.00138	0.0428	CbGeAlD
Levothyroxine—THRB—lung—chronic obstructive pulmonary disease	0.00138	0.0428	CbGeAlD
Levothyroxine—SLCO4A1—trachea—chronic obstructive pulmonary disease	0.00128	0.0397	CbGeAlD
Levothyroxine—SLC16A2—lung—chronic obstructive pulmonary disease	0.00125	0.0388	CbGeAlD
Levothyroxine—Cardiac failure congestive—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00694	CcSEcCtD
Levothyroxine—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00689	CcSEcCtD
Levothyroxine—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.00682	CcSEcCtD
Levothyroxine—Dysphagia—Tiotropium—chronic obstructive pulmonary disease	0.00117	0.00674	CcSEcCtD
Levothyroxine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00114	0.0066	CcSEcCtD
Levothyroxine—Angina pectoris—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00656	CcSEcCtD
Levothyroxine—Hypoglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00645	CcSEcCtD
Levothyroxine—Hypoglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00645	CcSEcCtD
Levothyroxine—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.0011	0.00633	CcSEcCtD
Levothyroxine—Increased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00632	CcSEcCtD
Levothyroxine—SLC7A5—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.00109	0.506	CbGdCrCtD
Levothyroxine—Menstruation irregular—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00616	CcSEcCtD
Levothyroxine—SLC7A5—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.00107	0.494	CbGdCrCtD
Levothyroxine—SLC7A5—lung—chronic obstructive pulmonary disease	0.00106	0.0327	CbGeAlD
Levothyroxine—Hypoglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00609	CcSEcCtD
Levothyroxine—TTR—lung—chronic obstructive pulmonary disease	0.00103	0.0318	CbGeAlD
Levothyroxine—Irritability—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00588	CcSEcCtD
Levothyroxine—Dehydration—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00585	CcSEcCtD
Levothyroxine—Dehydration—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00585	CcSEcCtD
Levothyroxine—Affect lability—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00585	CcSEcCtD
Levothyroxine—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.000981	0.00567	CcSEcCtD
Levothyroxine—Mood swings—Salbutamol—chronic obstructive pulmonary disease	0.000974	0.00563	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000961	0.00555	CcSEcCtD
Levothyroxine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000954	0.00551	CcSEcCtD
Levothyroxine—SLCO4A1—lung—chronic obstructive pulmonary disease	0.000923	0.0285	CbGeAlD
Levothyroxine—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.000919	0.00531	CcSEcCtD
Levothyroxine—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.000917	0.0053	CcSEcCtD
Levothyroxine—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.000917	0.0053	CcSEcCtD
Levothyroxine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000909	0.00525	CcSEcCtD
Levothyroxine—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000884	0.00511	CcSEcCtD
Levothyroxine—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000875	0.00505	CcSEcCtD
Levothyroxine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000869	0.00502	CcSEcCtD
Levothyroxine—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.000866	0.005	CcSEcCtD
Levothyroxine—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.000866	0.005	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000862	0.00498	CcSEcCtD
Levothyroxine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000846	0.00488	CcSEcCtD
Levothyroxine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000838	0.00484	CcSEcCtD
Levothyroxine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000837	0.00483	CcSEcCtD
Levothyroxine—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000834	0.00482	CcSEcCtD
Levothyroxine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000834	0.00482	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.000827	0.00478	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.000827	0.00478	CcSEcCtD
Levothyroxine—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.000823	0.00475	CcSEcCtD
Levothyroxine—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.000823	0.00475	CcSEcCtD
Levothyroxine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000807	0.00466	CcSEcCtD
Levothyroxine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000792	0.00457	CcSEcCtD
Levothyroxine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000761	0.0044	CcSEcCtD
Levothyroxine—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00076	0.00439	CcSEcCtD
Levothyroxine—Liotrix—ALB—chronic obstructive pulmonary disease	0.000758	0.578	CrCbGaD
Levothyroxine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000757	0.00437	CcSEcCtD
Levothyroxine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000747	0.00431	CcSEcCtD
Levothyroxine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000742	0.00429	CcSEcCtD
Levothyroxine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000731	0.00422	CcSEcCtD
Levothyroxine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000721	0.00417	CcSEcCtD
Levothyroxine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000718	0.00415	CcSEcCtD
Levothyroxine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000692	0.004	CcSEcCtD
Levothyroxine—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000692	0.004	CcSEcCtD
Levothyroxine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000686	0.00397	CcSEcCtD
Levothyroxine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000673	0.00389	CcSEcCtD
Levothyroxine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000673	0.00389	CcSEcCtD
Levothyroxine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00067	0.00387	CcSEcCtD
Levothyroxine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000665	0.00384	CcSEcCtD
Levothyroxine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000664	0.00384	CcSEcCtD
Levothyroxine—SLCO1A2—lung—chronic obstructive pulmonary disease	0.000661	0.0204	CbGeAlD
Levothyroxine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000661	0.00382	CcSEcCtD
Levothyroxine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00066	0.00381	CcSEcCtD
Levothyroxine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000652	0.00377	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.00065	0.00376	CcSEcCtD
Levothyroxine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000647	0.00374	CcSEcCtD
Levothyroxine—Tension—Formoterol—chronic obstructive pulmonary disease	0.000644	0.00372	CcSEcCtD
Levothyroxine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000644	0.00372	CcSEcCtD
Levothyroxine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000637	0.00368	CcSEcCtD
Levothyroxine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000637	0.00368	CcSEcCtD
Levothyroxine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000636	0.00367	CcSEcCtD
Levothyroxine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000635	0.00367	CcSEcCtD
Levothyroxine—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.000628	0.00363	CcSEcCtD
Levothyroxine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000626	0.00362	CcSEcCtD
Levothyroxine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000614	0.00355	CcSEcCtD
Levothyroxine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000614	0.00355	CcSEcCtD
Levothyroxine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000608	0.00351	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000604	0.00349	CcSEcCtD
Levothyroxine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000603	0.00348	CcSEcCtD
Levothyroxine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000603	0.00348	CcSEcCtD
Levothyroxine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000602	0.00348	CcSEcCtD
Levothyroxine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000601	0.00347	CcSEcCtD
Levothyroxine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.0006	0.00347	CcSEcCtD
Levothyroxine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000599	0.00346	CcSEcCtD
Levothyroxine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000599	0.00346	CcSEcCtD
Levothyroxine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00059	0.00341	CcSEcCtD
Levothyroxine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000587	0.00339	CcSEcCtD
Levothyroxine—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.00058	0.00335	CcSEcCtD
Levothyroxine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00058	0.00335	CcSEcCtD
Levothyroxine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00058	0.00335	CcSEcCtD
Levothyroxine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00058	0.00335	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000575	0.00332	CcSEcCtD
Levothyroxine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000569	0.00329	CcSEcCtD
Levothyroxine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000568	0.00328	CcSEcCtD
Levothyroxine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000566	0.00327	CcSEcCtD
Levothyroxine—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000561	0.00324	CcSEcCtD
Levothyroxine—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000559	0.00323	CcSEcCtD
Levothyroxine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000559	0.00323	CcSEcCtD
Levothyroxine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000558	0.00323	CcSEcCtD
Levothyroxine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000558	0.00323	CcSEcCtD
Levothyroxine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000557	0.00322	CcSEcCtD
Levothyroxine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000556	0.00321	CcSEcCtD
Levothyroxine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000556	0.00321	CcSEcCtD
Levothyroxine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000556	0.00321	CcSEcCtD
Levothyroxine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000556	0.00321	CcSEcCtD
Levothyroxine—Liothyronine—ALB—chronic obstructive pulmonary disease	0.000554	0.422	CrCbGaD
Levothyroxine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000547	0.00316	CcSEcCtD
Levothyroxine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000547	0.00316	CcSEcCtD
Levothyroxine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000545	0.00315	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000542	0.00313	CcSEcCtD
Levothyroxine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000527	0.00305	CcSEcCtD
Levothyroxine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000527	0.00304	CcSEcCtD
Levothyroxine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000525	0.00304	CcSEcCtD
Levothyroxine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000524	0.00303	CcSEcCtD
Levothyroxine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000522	0.00302	CcSEcCtD
Levothyroxine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000522	0.00302	CcSEcCtD
Levothyroxine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00052	0.003	CcSEcCtD
Levothyroxine—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000515	0.00297	CcSEcCtD
Levothyroxine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000498	0.00287	CcSEcCtD
Levothyroxine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000497	0.00287	CcSEcCtD
Levothyroxine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000496	0.00287	CcSEcCtD
Levothyroxine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000493	0.00285	CcSEcCtD
Levothyroxine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000489	0.00282	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000488	0.00282	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000488	0.00282	CcSEcCtD
Levothyroxine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000484	0.0028	CcSEcCtD
Levothyroxine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000484	0.0028	CcSEcCtD
Levothyroxine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000481	0.00278	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000478	0.00276	CcSEcCtD
Levothyroxine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000477	0.00276	CcSEcCtD
Levothyroxine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000477	0.00276	CcSEcCtD
Levothyroxine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000474	0.00274	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000473	0.00273	CcSEcCtD
Levothyroxine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000469	0.00271	CcSEcCtD
Levothyroxine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000461	0.00267	CcSEcCtD
Levothyroxine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000461	0.00267	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00046	0.00266	CcSEcCtD
Levothyroxine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000457	0.00264	CcSEcCtD
Levothyroxine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000456	0.00264	CcSEcCtD
Levothyroxine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000452	0.00261	CcSEcCtD
Levothyroxine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000451	0.0026	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000448	0.00259	CcSEcCtD
Levothyroxine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000447	0.00258	CcSEcCtD
Levothyroxine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000445	0.00257	CcSEcCtD
Levothyroxine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000443	0.00256	CcSEcCtD
Levothyroxine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000443	0.00256	CcSEcCtD
Levothyroxine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000441	0.00255	CcSEcCtD
Levothyroxine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000441	0.00255	CcSEcCtD
Levothyroxine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000441	0.00255	CcSEcCtD
Levothyroxine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000439	0.00254	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000438	0.00253	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000438	0.00253	CcSEcCtD
Levothyroxine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000436	0.00252	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000429	0.00248	CcSEcCtD
Levothyroxine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000425	0.00246	CcSEcCtD
Levothyroxine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000425	0.00246	CcSEcCtD
Levothyroxine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000423	0.00244	CcSEcCtD
Levothyroxine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000423	0.00244	CcSEcCtD
Levothyroxine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000423	0.00244	CcSEcCtD
Levothyroxine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000423	0.00244	CcSEcCtD
Levothyroxine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000422	0.00244	CcSEcCtD
Levothyroxine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000422	0.00244	CcSEcCtD
Levothyroxine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000418	0.00242	CcSEcCtD
Levothyroxine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000418	0.00241	CcSEcCtD
Levothyroxine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000418	0.00241	CcSEcCtD
Levothyroxine—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000417	0.0129	CbGeAlD
Levothyroxine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000416	0.00241	CcSEcCtD
Levothyroxine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000416	0.00241	CcSEcCtD
Levothyroxine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000415	0.0024	CcSEcCtD
Levothyroxine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000414	0.00239	CcSEcCtD
Levothyroxine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000414	0.00239	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000413	0.00239	CcSEcCtD
Levothyroxine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000409	0.00236	CcSEcCtD
Levothyroxine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000407	0.00235	CcSEcCtD
Levothyroxine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000406	0.00235	CcSEcCtD
Levothyroxine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000401	0.00232	CcSEcCtD
Levothyroxine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00231	CcSEcCtD
Levothyroxine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00231	CcSEcCtD
Levothyroxine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000394	0.00228	CcSEcCtD
Levothyroxine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000384	0.00222	CcSEcCtD
Levothyroxine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000384	0.00222	CcSEcCtD
Levothyroxine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000379	0.00219	CcSEcCtD
Levothyroxine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000379	0.00219	CcSEcCtD
Levothyroxine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000378	0.00218	CcSEcCtD
Levothyroxine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000376	0.00217	CcSEcCtD
Levothyroxine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000371	0.00214	CcSEcCtD
Levothyroxine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000366	0.00212	CcSEcCtD
Levothyroxine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000366	0.00212	CcSEcCtD
Levothyroxine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000364	0.00211	CcSEcCtD
Levothyroxine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00209	CcSEcCtD
Levothyroxine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000361	0.00208	CcSEcCtD
Levothyroxine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000359	0.00207	CcSEcCtD
Levothyroxine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.00207	CcSEcCtD
Levothyroxine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000346	0.002	CcSEcCtD
Levothyroxine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00034	0.00197	CcSEcCtD
Levothyroxine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00034	0.00197	CcSEcCtD
Levothyroxine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000337	0.00195	CcSEcCtD
Levothyroxine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000337	0.00195	CcSEcCtD
Levothyroxine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000337	0.00195	CcSEcCtD
Levothyroxine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000337	0.00195	CcSEcCtD
Levothyroxine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.00194	CcSEcCtD
Levothyroxine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000335	0.00194	CcSEcCtD
Levothyroxine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000335	0.00194	CcSEcCtD
Levothyroxine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000333	0.00193	CcSEcCtD
Levothyroxine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000331	0.00191	CcSEcCtD
Levothyroxine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00033	0.00191	CcSEcCtD
Levothyroxine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000328	0.0019	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000326	0.00188	CcSEcCtD
Levothyroxine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000325	0.00187	CcSEcCtD
Levothyroxine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000324	0.00187	CcSEcCtD
Levothyroxine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.00186	CcSEcCtD
Levothyroxine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000319	0.00184	CcSEcCtD
Levothyroxine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.00184	CcSEcCtD
Levothyroxine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000318	0.00184	CcSEcCtD
Levothyroxine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000318	0.00184	CcSEcCtD
Levothyroxine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00183	CcSEcCtD
Levothyroxine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000311	0.0018	CcSEcCtD
Levothyroxine—ABCB1—trachea—chronic obstructive pulmonary disease	0.000308	0.00952	CbGeAlD
Levothyroxine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000308	0.00178	CcSEcCtD
Levothyroxine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.0003	0.00173	CcSEcCtD
Levothyroxine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000285	0.00165	CcSEcCtD
Levothyroxine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000283	0.00163	CcSEcCtD
Levothyroxine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00028	0.00162	CcSEcCtD
Levothyroxine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000275	0.00159	CcSEcCtD
Levothyroxine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00153	CcSEcCtD
Levothyroxine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000262	0.00151	CcSEcCtD
Levothyroxine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000262	0.00151	CcSEcCtD
Levothyroxine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000239	0.00138	CcSEcCtD
Levothyroxine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000237	0.00137	CcSEcCtD
Levothyroxine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000236	0.00136	CcSEcCtD
Levothyroxine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00023	0.00133	CcSEcCtD
Levothyroxine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000224	0.00129	CcSEcCtD
Levothyroxine—ABCB1—lung—chronic obstructive pulmonary disease	0.000221	0.00684	CbGeAlD
Levothyroxine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00022	0.00127	CcSEcCtD
Levothyroxine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000219	0.00126	CcSEcCtD
Levothyroxine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000207	0.0012	CcSEcCtD
Levothyroxine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00119	CcSEcCtD
Levothyroxine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00118	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000192	0.00111	CcSEcCtD
Levothyroxine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00019	0.0011	CcSEcCtD
Levothyroxine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.00106	CcSEcCtD
Levothyroxine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.00105	CcSEcCtD
Levothyroxine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000182	0.00105	CcSEcCtD
Levothyroxine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.00105	CcSEcCtD
Levothyroxine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000174	0.001	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000995	CcSEcCtD
Levothyroxine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.000995	CcSEcCtD
Levothyroxine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000967	CcSEcCtD
Levothyroxine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000962	CcSEcCtD
Levothyroxine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000962	CcSEcCtD
Levothyroxine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000873	CcSEcCtD
Levothyroxine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000861	CcSEcCtD
Levothyroxine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000833	CcSEcCtD
Levothyroxine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000774	CcSEcCtD
Levothyroxine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000767	CcSEcCtD
Levothyroxine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000767	CcSEcCtD
Levothyroxine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000762	CcSEcCtD
Levothyroxine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000723	CcSEcCtD
Levothyroxine—SLC7A5—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000102	0.00141	CbGpPWpGaD
Levothyroxine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000102	0.00141	CbGpPWpGaD
Levothyroxine—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.96e-05	0.00138	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—APIP—chronic obstructive pulmonary disease	9.85e-05	0.00136	CbGpPWpGaD
Levothyroxine—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.84e-05	0.00136	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	9.84e-05	0.00136	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	9.78e-05	0.00135	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	9.31e-05	0.00129	CbGpPWpGaD
Levothyroxine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	9.27e-05	0.00128	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	9.12e-05	0.00126	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	9.06e-05	0.00125	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	8.99e-05	0.00124	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.93e-05	0.00123	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	8.76e-05	0.00121	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	8.76e-05	0.00121	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	8.75e-05	0.00121	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	8.62e-05	0.00119	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—ALB—chronic obstructive pulmonary disease	8.61e-05	0.00119	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	8.49e-05	0.00117	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—APIP—chronic obstructive pulmonary disease	8.42e-05	0.00116	CbGpPWpGaD
Levothyroxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	8.36e-05	0.00116	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.3e-05	0.00115	CbGpPWpGaD
Levothyroxine—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.28e-05	0.00114	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—NOS3—chronic obstructive pulmonary disease	8.23e-05	0.00114	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	8.23e-05	0.00114	CbGpPWpGaD
Levothyroxine—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.16e-05	0.00113	CbGpPWpGaD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.15e-05	0.00112	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.15e-05	0.00112	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—GC—chronic obstructive pulmonary disease	8.07e-05	0.00112	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	7.86e-05	0.00109	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	7.68e-05	0.00106	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	7.68e-05	0.00106	CbGpPWpGaD
Levothyroxine—SLCO1B3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	7.61e-05	0.00105	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	7.59e-05	0.00105	CbGpPWpGaD
Levothyroxine—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	7.51e-05	0.00104	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.51e-05	0.00104	CbGpPWpGaD
Levothyroxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.5e-05	0.00104	CbGpPWpGaD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.45e-05	0.00103	CbGpPWpGaD
Levothyroxine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.4e-05	0.00102	CbGpPWpGaD
Levothyroxine—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	7.16e-05	0.000988	CbGpPWpGaD
Levothyroxine—TTR—Disease—HDAC2—chronic obstructive pulmonary disease	7.15e-05	0.000987	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	7.12e-05	0.000983	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.02e-05	0.00097	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7e-05	0.000967	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	6.96e-05	0.000961	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.96e-05	0.000961	CbGpPWpGaD
Levothyroxine—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.9e-05	0.000953	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	6.85e-05	0.000946	CbGpPWpGaD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.83e-05	0.000943	CbGpPWpGaD
Levothyroxine—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.81e-05	0.00094	CbGpPWpGaD
Levothyroxine—TTR—Disease—KL—chronic obstructive pulmonary disease	6.65e-05	0.000918	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.52e-05	0.000901	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.47e-05	0.000893	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.44e-05	0.000889	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	6.35e-05	0.000877	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GC—chronic obstructive pulmonary disease	6.34e-05	0.000876	CbGpPWpGaD
Levothyroxine—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.34e-05	0.000876	CbGpPWpGaD
Levothyroxine—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.26e-05	0.000864	CbGpPWpGaD
Levothyroxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.08e-05	0.000839	CbGpPWpGaD
Levothyroxine—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.01e-05	0.000831	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6e-05	0.000829	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.98e-05	0.000826	CbGpPWpGaD
Levothyroxine—SLCO1A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	5.98e-05	0.000826	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—VEGFA—chronic obstructive pulmonary disease	5.93e-05	0.000819	CbGpPWpGaD
Levothyroxine—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.93e-05	0.000819	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.9e-05	0.000815	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	5.65e-05	0.000781	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	5.63e-05	0.000778	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.58e-05	0.00077	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.53e-05	0.000764	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—TGFB1—chronic obstructive pulmonary disease	5.44e-05	0.000752	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	5.43e-05	0.000749	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	5.4e-05	0.000746	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.35e-05	0.000738	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	5.29e-05	0.00073	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	5.29e-05	0.00073	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.28e-05	0.00073	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	5.28e-05	0.000729	CbGpPWpGaD
Levothyroxine—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	5.17e-05	0.000714	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	5.17e-05	0.000713	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	5.12e-05	0.000708	CbGpPWpGaD
Levothyroxine—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	5.11e-05	0.000706	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.06e-05	0.000699	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.04e-05	0.000697	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.01e-05	0.000691	CbGpPWpGaD
Levothyroxine—TTR—Disease—ERBB3—chronic obstructive pulmonary disease	4.98e-05	0.000688	CbGpPWpGaD
Levothyroxine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	4.92e-05	0.00068	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	4.84e-05	0.000668	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	4.81e-05	0.000664	CbGpPWpGaD
Levothyroxine—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	4.74e-05	0.000655	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.7e-05	0.000649	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.65e-05	0.000643	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	4.57e-05	0.000632	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	4.55e-05	0.000629	CbGpPWpGaD
Levothyroxine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	4.52e-05	0.000624	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	4.51e-05	0.000623	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—TP53—chronic obstructive pulmonary disease	4.48e-05	0.000619	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.44e-05	0.000614	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.41e-05	0.000609	CbGpPWpGaD
Levothyroxine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.38e-05	0.000605	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—GCLC—chronic obstructive pulmonary disease	4.36e-05	0.000602	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.33e-05	0.000597	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.3e-05	0.000593	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	4.21e-05	0.000582	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	4.2e-05	0.00058	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	4.17e-05	0.000576	CbGpPWpGaD
Levothyroxine—TTR—Disease—NOS2—chronic obstructive pulmonary disease	4.15e-05	0.000574	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.1e-05	0.000567	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.07e-05	0.000562	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.02e-05	0.000555	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CTGF—chronic obstructive pulmonary disease	3.98e-05	0.00055	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.92e-05	0.000541	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	3.91e-05	0.000541	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.87e-05	0.000534	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.84e-05	0.00053	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.71e-05	0.000512	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.67e-05	0.000506	CbGpPWpGaD
Levothyroxine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.65e-05	0.000505	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	3.51e-05	0.000485	CbGpPWpGaD
Levothyroxine—TTR—Disease—SERPINE1—chronic obstructive pulmonary disease	3.5e-05	0.000483	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.49e-05	0.000482	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.47e-05	0.000479	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.45e-05	0.000476	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.43e-05	0.000474	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	3.43e-05	0.000473	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.4e-05	0.00047	CbGpPWpGaD
Levothyroxine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.36e-05	0.000464	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.36e-05	0.000464	CbGpPWpGaD
Levothyroxine—TTR—Disease—NOS3—chronic obstructive pulmonary disease	3.34e-05	0.000461	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	3.33e-05	0.00046	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.31e-05	0.000457	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.23e-05	0.000446	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.2e-05	0.000443	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.19e-05	0.000441	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.19e-05	0.00044	CbGpPWpGaD
Levothyroxine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.18e-05	0.00044	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.18e-05	0.000439	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	3.17e-05	0.000437	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.16e-05	0.000436	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.13e-05	0.000432	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.12e-05	0.000431	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	3.12e-05	0.000431	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GC—chronic obstructive pulmonary disease	3.1e-05	0.000428	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.06e-05	0.000422	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.04e-05	0.000419	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.02e-05	0.000416	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.96e-05	0.000409	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.93e-05	0.000405	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.9e-05	0.0004	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.88e-05	0.000398	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.88e-05	0.000398	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.81e-05	0.000388	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.79e-05	0.000386	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.73e-05	0.000377	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.72e-05	0.000375	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.67e-05	0.000369	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.66e-05	0.000368	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.6e-05	0.000359	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.6e-05	0.000359	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.52e-05	0.000349	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.47e-05	0.000341	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.46e-05	0.00034	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.45e-05	0.000338	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.4e-05	0.000332	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.37e-05	0.000327	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.34e-05	0.000323	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.31e-05	0.000319	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.3e-05	0.000317	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.29e-05	0.000317	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.26e-05	0.000312	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.26e-05	0.000312	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.22e-05	0.000307	CbGpPWpGaD
Levothyroxine—TTR—Disease—TGFB1—chronic obstructive pulmonary disease	2.21e-05	0.000305	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.21e-05	0.000305	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.17e-05	0.000299	CbGpPWpGaD
Levothyroxine—TTR—Disease—EGFR—chronic obstructive pulmonary disease	2.17e-05	0.000299	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.1e-05	0.000291	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.09e-05	0.000289	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.07e-05	0.000287	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.07e-05	0.000286	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.05e-05	0.000284	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.04e-05	0.000282	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.03e-05	0.00028	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.03e-05	0.00028	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.93e-05	0.000267	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.89e-05	0.000261	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.88e-05	0.000259	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—ALB—chronic obstructive pulmonary disease	1.81e-05	0.00025	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.79e-05	0.000247	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.73e-05	0.000239	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.72e-05	0.000238	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.72e-05	0.000237	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.71e-05	0.000236	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.7e-05	0.000235	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.69e-05	0.000234	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.68e-05	0.000233	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.68e-05	0.000233	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.67e-05	0.000231	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.67e-05	0.000231	CbGpPWpGaD
Levothyroxine—TTR—Disease—IL6—chronic obstructive pulmonary disease	1.66e-05	0.00023	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.64e-05	0.000226	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.57e-05	0.000217	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.56e-05	0.000215	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.55e-05	0.000214	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.54e-05	0.000212	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.53e-05	0.000211	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.52e-05	0.000209	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.48e-05	0.000205	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.47e-05	0.000203	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.42e-05	0.000196	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.42e-05	0.000195	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.41e-05	0.000194	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.36e-05	0.000188	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.34e-05	0.000185	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.3e-05	0.00018	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.27e-05	0.000176	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.23e-05	0.00017	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	1.22e-05	0.000168	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.18e-05	0.000163	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.18e-05	0.000163	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.17e-05	0.000162	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.17e-05	0.000161	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.16e-05	0.000161	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.16e-05	0.000161	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.16e-05	0.00016	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.08e-05	0.00015	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.08e-05	0.00015	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.08e-05	0.000149	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.03e-05	0.000142	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.03e-05	0.000142	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.02e-05	0.000141	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.01e-05	0.00014	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.45e-06	0.000131	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.14e-06	0.000126	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	9.04e-06	0.000125	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.96e-06	0.000124	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	8.93e-06	0.000123	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	8.25e-06	0.000114	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.6e-06	0.000105	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	6.99e-06	9.65e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	6.69e-06	9.24e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	6.65e-06	9.18e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.34e-06	8.75e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.25e-06	8.63e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	6.09e-06	8.41e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.83e-06	8.05e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.82e-06	8.04e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.52e-06	7.62e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.75e-06	5.18e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.59e-06	4.96e-05	CbGpPWpGaD
